can semaglutide cause low potassium Hypokalemia Requiring Hospitalization After Taking Injections Best electrolytes for GLP-1: guide

In rare cases, there could be a risk of temporary hyperpigmentation (your skin getting darker) or hypopigmentation (your skin getting lighter), especially if you have a darker skin tone

However, established compounding networks with robust compliance programs are positioned to absorb increased demand if consolidation occurs

This pattern differs from what typically occurs during caloric restriction and from what the Retatrutide data showed

Therefore, there is still the need for the discovery and/or development of a drug candidate characterized by at least a comparable pain-relieving effect to opioids but with a much better safety profile in terms of expected adverse reactions

These results confirm that the cardiovascular protection seen with injectable GLP-1 agonists extends to the oral formulation, an important finding that strengthens the case for offering patients a choice of delivery method based on their preferences rather than effectiveness alone

Results: A total of 1,829 reports were identified in which GLP-1 RAs were listed as the primary suspect drug, involving 1,651 patients